For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231012:nRSL9507Pa&default-theme=true
RNS Number : 9507P Baronsmead Venture Trust PLC 12 October 2023
12 October 2023
Baronsmead Venture Trust plc
("BVT" or the "Company")
Appointment of Non-Executive Director
The Board of Baronsmead Venture Trust plc is pleased to announce the
appointment of Isabel Dolan as an independent Non-Executive Director of the
Company, the Chair of the Audit Committee and a member of the Management
Engagement & Remuneration Committee and Nomination Committee, with effect
from 1 November 2023.
Isabel has over 25 years' experience working with growth companies as a
corporate financier, equity investor, lender and as a Finance Director. Her
previous roles include her working with RBS and 3i, and, until 2013, as
Operations Partner for Albion Capital, specialising in the finance, operations
and administration of venture capital trusts.
She has been a Non-Executive Director and Chair of the Audit Committee for a
NHS Trust, and is currently Chair of St Albans Community Bank.
Isabel is an FCA and holds an MBA from London Business School.
Fiona Miller-Smith, Chair of the Company, commented on the appointment:
"We are delighted that Isabel has agreed to join us and welcome her to an
already talented Board. Isabel brings some really relevant experience from her
time at 3i and Albion Ventures as well as a wider perspective of growth
companies. We all very much look forward to working with her."
There are no further items requiring disclosure under Listing Rule 9.6.13
regarding Isabel Dolan's appointment.
For further information, please contact:
Baronsmead VCT Investor Relations
020 7382 0999
baronsmeadvcts@greshamhouse.com (mailto:baronsmeadvcts@greshamhouse.com)
LEI: 213800VQ1PQHOJXDDQ88
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOABLLFFXBLFFBD